| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8531915 | Journal of the American Pharmacists Association | 2018 | 6 Pages |
Abstract
Despite warnings, the majority of pharmacists would still inappropriately recommend a benzocaine-containing product for treatment of infant teething. Further education is warranted to ensure that all pharmacists, health care providers, and consumers are aware of the potential harm of benzocaine use in infants.
Related Topics
Health Sciences
Medicine and Dentistry
Public Health and Health Policy
Authors
Eric J. Ip, Punam B. Patel, Josephine J. Chi, Bijal Shah-Manek, Bonnie Lau,